NCT04836975View on ClinicalTrials.gov

Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Lung Cancer
Trial Locations (1)

Unknown

Research Site, Riyadh

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY